Molecular fluorescence‐guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review

摘要

Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over‐ and under‐treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.